A suspicious package at an AstraZeneca COVID-19 vaccine plant in Wales which forced a temporary suspension of manufacturing has been made safe and production schedules of the shots have not been affected, the company Wockhardt UK said on Wednesday. The Wockhardt plant in Wrexham provides so-called fill-and-finish capacity for AstraZeneca’s UK supply chain, which is… Read More UK AstraZeneca vaccine factory evacuated over suspicious package
AstraZeneca’s COVID-19 vaccine has been approved for emergency use in Pakistan, the health minister said on Saturday, making it the first coronavirus vaccine to get the green light for use in the South Asian country. Pakistan, which is seeing rising numbers of coronavirus infections, said its vaccines would be procured from multiple sources. “DRAP granted… Read More Pakistan approves AstraZeneca coronavirus vaccine for emergency use
Kenya has ordered 24 million doses of the COVID-19 vaccine developed by AstraZeneca and expects them to start arriving in the second week of February, its health minister said. The East African nation of around 47 million people has so far reported 97,398 cases of COVID-19 and 1,694 deaths. Its economy is also reeling from… Read More Kenya orders 24 million doses of AstraZeneca coronavirus vaccine
Morocco’s health ministry on Wednesday approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use, Health Minister Khalid Ait Taleb said. Morocco had announced it plans to launch a free vaccination campaign targeting 25 million people, or 80% of its population. The country has ordered 66 million doses from AstraZeneca and China’s… Read More Morocco approves use of AstraZeneca/Oxford coronavirus vaccine
India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter said. The decision clears the vaccine’s rollout in the world’s second-most populous country which, after the United States, has the highest number of COVID-19 infections. India wants to start administering… Read More India approves use of AstraZeneca coronavirus vaccine
Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus. AstraZeneca said the authorisation was for a two dose regime, and that the vaccine had been approved… Read More Britain approves use of AstraZeneca/Oxford coronavirus vaccine
AstraZeneca Plc will acquire U.S. based Alexion Pharmaceuticals in a $39 billion deal, the company said in a statement on Saturday. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share, the company said.
Australia will receive the first doses of an AstraZeneca and Oxford University COVID-19 vaccine in January 2021 if trials prove successful, after Canberra agreed a deal to purchase a second potential vaccine, Prime Minister Scott Morrison will say on Monday. Australia said in August it had signed a preliminary agreement with AstraZeneca for enough doses… Read More Australia to receive first batch of AstraZeneca coronavirus vaccine in January 2021